2'-Deoxycytidine-13C9,15N3

2'-Deoxycytidine-13C9,15N3 (Deoxycytidine-13C9,15N3; Cytosine deoxyriboside-13C9,15N3; Deoxyribose cytidine-13C9,15N3) is 13C and 15N-labeled 2'-Deoxycytidine (HY-D0184) . 2'-Deoxycytidine, a deoxyribonucleoside, could inhibit biological effects of Bromodeoxyuridine (Brdu) .

Product Specifications

CAS Number

[1987883-22-6]

Product Name Alternative

Deoxycytidine-13C9,15N3; Cytosine deoxyriboside-13C9,15N3; Deoxyribose cytidine-13C9,15N3

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

Endogenous Metabolite; Isotope-Labeled Compounds

Type

Isotope-Labeled Compounds

Related Pathways

Metabolic Enzyme/Protease; Others

Field of Research

Others

Assay Protocol

https://www.medchemexpress.com/2-deoxycytidine-13c9-15n3.html

Concentration

100 mM * 41.82 μL in Water

Purity

99.00

Solubility

10 mM in DMSO

Smiles

O=[13C]1[15N]([13C@H]2[13CH]([H])[13CH](O)[13C@@H]([13CH2]O)O2)[13CH]=[13CH][13C]([15NH2])=[15N]1

Molecular Formula

13C9H13 15N3O4

Molecular Weight

239.13

Precautions

H302, H315, H319, H335

References & Citations

[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53 (2) :211-216.|[2]Horn D, et al. Inhibition of biological effects of bromodeoxyuridine by deoxycytidine: correlation with decreased incorporation of bromodeoxyuridine into DNA. Somatic Cell Genet. 1976 Sep;2 (5) :469-81.